# Daniel Cattran

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daniel-cattran/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,055 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 53 |
| i10-index | 91 |
| Last Known Institution | University of Toronto |
| OpenAlex ID | https://openalex.org/A5107379274 |
| Works | 154 |

## Researcher papers

- [The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility](https://scholariq.org/papers/the-oxford-classification-of-iga-nephropathy-pathology-definitions-correlations/)
- [Remission of Proteinuria Improves Prognosis in IgA Nephropathy](https://scholariq.org/papers/remission-of-proteinuria-improves-prognosis-in-iga-nephropathy/)
- [Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy](https://scholariq.org/papers/rituximab-or-cyclosporine-in-the-treatment-of-membranous-nephropathy/)
- [Evaluating a New International Risk-Prediction Tool in IgA Nephropathy](https://scholariq.org/papers/evaluating-a-new-international-risk-prediction-tool-in-iga-nephropathy/)
- [Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy](https://scholariq.org/papers/rituximab-induced-depletion-of-anti-pla2r-autoantibodies-predicts-response-in/)
- [The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patient](https://scholariq.org/papers/the-kdigo-practice-guideline-on-glomerulonephritis-reading-between-the-guide/)
- [Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial](https://scholariq.org/papers/cyclosporine-in-patients-with-steroid-resistant-membranous-nephropathy-a/)
- [Predicting progression in IgA nephropathy](https://scholariq.org/papers/predicting-progression-in-iga-nephropathy/)
- [A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis](https://scholariq.org/papers/a-randomized-trial-of-cyclosporine-in-patients-with-steroid-resistant-focal/)
- [Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN](https://scholariq.org/papers/mayo-clinic-renal-pathology-society-consensus-report-on-pathologic/)
- [Membranous nephropathy: thinking through the therapeutic options](https://scholariq.org/papers/membranous-nephropathy-thinking-through-the-therapeutic-options/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [University of Toronto](https://scholariq.org/institutions/university-of-toronto/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.